ATE311871T1 - Verwendung von zinksalzen der konjugierten linoleinsäuren zur behandlung von hautkrankheiten - Google Patents

Verwendung von zinksalzen der konjugierten linoleinsäuren zur behandlung von hautkrankheiten

Info

Publication number
ATE311871T1
ATE311871T1 AT97909433T AT97909433T ATE311871T1 AT E311871 T1 ATE311871 T1 AT E311871T1 AT 97909433 T AT97909433 T AT 97909433T AT 97909433 T AT97909433 T AT 97909433T AT E311871 T1 ATE311871 T1 AT E311871T1
Authority
AT
Austria
Prior art keywords
treatment
skin diseases
zinc salts
conjugated linoleic
linoleic acids
Prior art date
Application number
AT97909433T
Other languages
English (en)
Inventor
Derek Bryce-Smith
Original Assignee
Kappa Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kappa Pharmaceuticals Ltd filed Critical Kappa Pharmaceuticals Ltd
Application granted granted Critical
Publication of ATE311871T1 publication Critical patent/ATE311871T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/315—Zinc compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT97909433T 1996-10-17 1997-10-16 Verwendung von zinksalzen der konjugierten linoleinsäuren zur behandlung von hautkrankheiten ATE311871T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9621630.4A GB9621630D0 (en) 1996-10-17 1996-10-17 Treatment of skin disorders
PCT/GB1997/002854 WO1998017269A1 (en) 1996-10-17 1997-10-16 Use of zinc salts of conjugated linoleic acids to treat skin disorders

Publications (1)

Publication Number Publication Date
ATE311871T1 true ATE311871T1 (de) 2005-12-15

Family

ID=10801560

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97909433T ATE311871T1 (de) 1996-10-17 1997-10-16 Verwendung von zinksalzen der konjugierten linoleinsäuren zur behandlung von hautkrankheiten

Country Status (10)

Country Link
US (2) US6300374B1 (de)
EP (1) EP1014967B1 (de)
JP (1) JP4243353B2 (de)
AT (1) ATE311871T1 (de)
AU (1) AU718611B2 (de)
DE (1) DE69734838T2 (de)
ES (1) ES2253772T3 (de)
GB (1) GB9621630D0 (de)
NZ (1) NZ334593A (de)
WO (1) WO1998017269A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6019990A (en) * 1997-11-21 2000-02-01 Natural Nutrition Ltd. As Conjugated linoleic acid delivery system in cosmetic preparations
GB9828379D0 (en) * 1998-12-22 1999-02-17 Unilever Plc Skin care composition
GB9828380D0 (en) * 1998-12-22 1999-02-17 Unilever Plc Skin lightening composition
WO2000050057A1 (en) * 1999-02-22 2000-08-31 Bernstein Eric F Compositions and methods for prevention of photoaging
AU6402700A (en) * 1999-07-09 2001-01-30 Monsanto Company Treatment of cyclooxygenase-2 mediated disorders using conjugated fatty acid compounds
GB9918025D0 (en) * 1999-07-30 1999-09-29 Unilever Plc Skin care composition
GB9918028D0 (en) * 1999-07-30 1999-09-29 Unilever Plc Skin care composition
ITMI991894A1 (it) 1999-09-09 2001-03-09 Carlo Ghisalberti Acido linoleico coniugato e trigliceride nuovi metodi di sintesi e d'uso
FR2802099A1 (fr) * 1999-12-08 2001-06-15 Fabre Pierre Cosmetique Thiosalicylate de zinc, compositions dermatologiques le contenant, en particulier sous la forme d'un dispositif auto-adhesif ainsi que le procede de preparation de ce dernier
AU2001256334A1 (en) * 2000-05-05 2001-11-20 Fresenius Kabi Deutschland Gmbh Combination preparation consisting of omega-3-fatty acids and of conjugated linoleic acids for treating immunologically oriented clinical signs
US20030143165A1 (en) * 2002-01-25 2003-07-31 Allan Evans NSAID-containing topical formulations that demonstrate chemopreventive activity
TW200407172A (en) * 2002-10-17 2004-05-16 Unilever Nv Scalp treatment
KR20130064825A (ko) 2002-10-25 2013-06-18 레반스 테라퓨틱스, 아이엔씨. 조직 특성을 개선하기 위한 아연 수준의 조절
US20080193550A1 (en) * 2004-05-11 2008-08-14 Fonterra Corporate Research And Development Limited Cla-Enriched Milkfat and Uses Thereof
US7767713B2 (en) * 2004-08-05 2010-08-03 Palo Alto Investors Linoleic acid active agents for enhancing probability of becoming pregnant
NZ543486A (en) * 2005-11-10 2009-03-31 Fonterra Corporate Res And Dev Compositions of CIS-9, trans-11 conjugated linoleic acid and vaccenic acid and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ4032U1 (cs) * 1993-05-17 1995-10-25 Miroslav Ing. Štol Farmaceutická kompozice pro topickou zevní aplikaci
GB9323808D0 (en) * 1993-11-18 1994-01-05 Alpha Healthcare Ltd Composition containing zinc for the treatment of skin disorders
US6025334A (en) * 1994-04-28 2000-02-15 Les Laboratoires Aeterna Inc. Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities; process of making, methods of using and compositions thereof

Also Published As

Publication number Publication date
US6300374B1 (en) 2001-10-09
GB9621630D0 (en) 1996-12-11
NZ334593A (en) 2000-01-28
WO1998017269A1 (en) 1998-04-30
AU718611B2 (en) 2000-04-20
DE69734838T2 (de) 2006-08-17
ES2253772T3 (es) 2006-06-01
EP1014967B1 (de) 2005-12-07
AU4711997A (en) 1998-05-15
JP2001502346A (ja) 2001-02-20
JP4243353B2 (ja) 2009-03-25
US6288115B1 (en) 2001-09-11
DE69734838D1 (de) 2006-01-12
EP1014967A1 (de) 2000-07-05

Similar Documents

Publication Publication Date Title
ATE321525T1 (de) Verwendung von konjugierten linolensaüren zur topischen behandlung von zellulitis
DE69734838D1 (de) Verwendung von zinksalzen der konjugierten linoleinsäuren zur behandlung von hautkrankheiten
ATE356113T1 (de) Probucolbernsteinsäureester zur hemmung der expression von vcam-1
DE69733132D1 (de) Verwendung von antioxidantien zur behandlung cholestatischer lebererkrankungen
DE69910560D1 (de) Wasserlöslische prodrugs von 2,6-diisopropylphenol-analoga
ATE259215T1 (de) Zusammensetzung zur regulierung des hauterscheinungsbildes
ATE258796T1 (de) Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
DE60231050D1 (de) Verwendung von Totarol zur Behandlung von Pruritus
ATE415962T1 (de) Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs
ATE160561T1 (de) L-carnitin-salz, dieses enthaltende kosmetische und pharmazeutische zusammensetzungen zur behandlung von dermatosen
ATE284217T1 (de) Verwendung von sulphoquinovosyldiacylglycerols zur behandlung von entzündlichen hauterkrankungen
DE69806622D1 (de) Kosmetische formulierungen zur verhütung und behandlung von haarausfall
DE69825279D1 (de) Verwendung von glukosamin und glukosaminderivaten zur schnellen linderung von juckreiz oder lokalisiertem schmerz
ATE267837T1 (de) Betulinsäure-derivate mit antiangiogener wirkung, verfahren zur herstellung solcher derivate und deren verwendung für die behandlung tumorassoziierter angiogenese
DE69229780T2 (de) Zusammensetzung und methode zur behandlung von störungen in form von depigmentierung
DE59508366D1 (de) Verwendung von boswelliasäure zur behandlung von hirntumoren
DE69932922D1 (de) Verwendung von alkansäuren-enthaltenden zusammensetzungen zur behandlung von nagelpilz-erkrankungen
DE59900286D1 (de) Verwendung von sphingosin-1-phosphat, sphingosin-1-phosphat-derivaten und/oder deren gemische zur behandlung von entzündlichen hautkrankheiten
DE69900774D1 (de) Verwendung von topische präparationen mit glyceryl trinitrat und lanolin zur behandlung von erektilen funktionsstörungen
ATE369143T1 (de) Verwendung von ngali nussöl zur behandlung/linderung der arthritisschmerzen und anderer ähnlichen störungen
MX9700113A (es) Amido-quinoxalindionas novedosas, su preparacion y uso.
AP2000002004A0 (en) Method of treatment for dermatological disorders and compositions therefor.
DE69831336D1 (de) Tazaroten und uvb-phototherapie zur behandlung von psoriasis
UA32151A (uk) Склад для лікування псоріазу
DE60012718D1 (de) Prognose von ptp lar vermittelten krankheiten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties